These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Comparison between iodine 123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure. Somsen GA; Szabó BM; van Veldhuisen DJ; de Milliano PA; de Groot CA; Lie KI Am Heart J; 1997 Sep; 134(3):456-8. PubMed ID: 9327702 [TBL] [Abstract][Full Text] [Related]
65. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy. Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474 [TBL] [Abstract][Full Text] [Related]
66. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. Dutka DP; Olivotto I; Ward S; Nihoyannopoulos P; al-Subaili M; Oakley CM; Impallomeni M; Cleland JG Eur Heart J; 1995 Sep; 16(9):1223-30. PubMed ID: 8582385 [TBL] [Abstract][Full Text] [Related]
67. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522 [TBL] [Abstract][Full Text] [Related]
68. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines. Missouris CG; Grouzmann E; Buckley MG; Barron J; MacGregor GA; Singer DR Clin Sci (Lond); 1998 Jun; 94(6):591-9. PubMed ID: 9854456 [TBL] [Abstract][Full Text] [Related]
69. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide. Sugihara K; Fujimoto S; Motomiya Y; Hashimoto T; Nakamura S; Dohi K Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091 [TBL] [Abstract][Full Text] [Related]
70. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574 [TBL] [Abstract][Full Text] [Related]
71. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease]. Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194 [TBL] [Abstract][Full Text] [Related]
72. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects. Rocco S; Opocher G; Carpenè G; Mantero F Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872 [TBL] [Abstract][Full Text] [Related]
73. Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy. Tsukamoto T; Morita K; Naya M; Inubushi M; Katoh C; Nishijima K; Kuge Y; Okamoto H; Tsutsui H; Tamaki N J Nucl Med; 2007 Nov; 48(11):1777-82. PubMed ID: 17942801 [TBL] [Abstract][Full Text] [Related]
74. Atrial natriuretic peptide ANP(1-98) and ANP(99-126) in patients with severe chronic congestive heart failure: relation to echocardiographic measurements. A subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Eriksson SV; Caidahl K; Hall C; Eneroth P; Kjekshus J; Offstad J; Swedberg K J Card Fail; 1995 Mar; 1(2):109-16. PubMed ID: 9420640 [TBL] [Abstract][Full Text] [Related]
75. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. Brunner-La Rocca HP; Kaye DM; Woods RL; Hastings J; Esler MD J Am Coll Cardiol; 2001 Apr; 37(5):1221-7. PubMed ID: 11300426 [TBL] [Abstract][Full Text] [Related]
76. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. Arimoto T; Takeishi Y; Niizeki T; Nozaki N; Hirono O; Watanabe T; Nitobe J; Tsunoda Y; Suzuki S; Koyama Y; Kitahara T; Okada A; Takahashi K; Kubota I J Card Fail; 2007 Feb; 13(1):34-41. PubMed ID: 17339001 [TBL] [Abstract][Full Text] [Related]
77. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
79. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure]. Indolfi C; Piscione F; Volpe M; Lembo G; De Campora P; Russolillo E; Ambrosini V; Condorelli M; Chiariello M Cardiologia; 1991 May; 36(5):351-6. PubMed ID: 1836751 [TBL] [Abstract][Full Text] [Related]